Equity Brief · Healthcare2026-05-20
SYK·Healthcare

Stryker Corporation

I · KI-Analyse

Kurzfassung

Stryker develops and sells medical devices for hospitals and doctors in two main segments: MedSurg/Neurotechnology (surgical tools, emergency equipment, stroke treatment devices, robotics) and Orthopaedics (hip/knee/shoulder implants, the Mako robotic surgery platform) [Yahoo Finance]. They operate in approximately 61 countries through their own sales teams and third-party distributors [Yahoo Finance].

Stryker Corporation is a $121.8 billion medical technology company that makes surgical equipment, robotic systems, and joint replacement implants sold to hospitals worldwide [Yahoo Finance]. The company reported strong revenue growth of +11.2% year-over-year to $25.1 billion, though recent news notes Q1 2026 earnings missed estimates due to a cyber incident [Yahoo Finance]. Financially, Stryker scores 10.0/10 for health with solid free cash flow of $4.3 billion, but the stock has dropped 21.4% over the past year [Yahoo Finance].

Stryker is financially robust with excellent margins, strong cash generation, and low leverage.

Kurzfassung AI analysisKonfidenz 8/10

Sentinellis-Score

10/10

Financially healthy

Marktkapitalisierung

$121.8B

Umsatz (12 Monate)

$25.1B

II · Aktuelle Nachrichten

Was den Kurs bewegt hat

5 stories · ranked by relevance

  • macro2026-05-18

    PAHC or SYK: Which Is the Better Value Stock Right Now?

    Yahoo Finance

  • macro2026-05-19

    BioStar Capital-Backed Amplitude Vascular Systems’ $835M Acquisition by Stryker Reflects Strength of Michigan’s Medtech Ecosystem

    Yahoo Finance

  • macro2026-05-16

    Is There Now An Opportunity In Stryker (SYK) After Recent Share Price Pullback

    Simply Wall St

  • macro2026-05-15

    Is Stryker Corporation (SYK) Under Pressure? Truist Lowers Outlook but Keeps Hold Rating

    Yahoo Finance

  • macro2026-05-15

    Surgical Robotics Meets AI: Intuitive Surgical, Medtronic, and Stryker Are the Sleeper Plays of the Healthcare Boom

    Yahoo Finance

Premium · kostenlos mit jedem Konto

Stryker trades at a PE ratio of 36.8x, which is elevated relative to historical norms and leaves the stock vulnerable to significant correction if earnings disappoint, especially with the next earnings report due July 30, 2026 [Yahoo Finance] [EODHD]

1 von 4 Risiken in diesem Bericht

Risiken

4

Chancen

6

Warnsignale

2

Führung

10

21 weitere Erkenntnisse im vollständigen Bericht — kostenlos mit jedem Konto.

Vollständige Stryker Corporation-Analyse freischalten

Erstellen Sie ein kostenloses Konto für den vollständigen KI-Bericht mit Quellenangaben im Text.

  • 4 Risiken, 6 Chancen und 2 Warnsignale — jeweils mit Quelle
  • Über 100 Finanzkennzahlen mit Charts und Vergleichen
  • Vollständige Nachrichten-Zusammenfassungen mit Quellenlinks
  • Führungsteam und Vergütung
  • PDF-Export für offline
Alle 12 Erkenntnisse freischalten3 kostenlose Berichte · keine Karte

III · Ähnliche Unternehmen

Das könnte Sie auch interessieren

Same sector · Healthcare or comparable health

Auf Ihre Watchlist setzen?

Read three companies free. Keine Karte.

3 kostenlose Berichte sichern